Cite
HARVARD Citation
Hampel, P. et al. (n.d.). Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare. American journal of hematology. 95 (3), pp. E57-E60. [Online].